Dexur

What Dexur does

Dexur (legal entity Dexur Enterprises Private Limited, Florida; headquarters listed in Cheyenne, Wyoming, with an Orlando, Florida office) is a private healthcare predictive analytics SaaS company founded in 2010 that sells a unified Quality, Safety, Risk, and Incident Management platform to hospitals, health systems, and related healthcare organizations. The company's technology is built on a CMS-approved Medicare claims dataset covering roughly 17M yearly inpatient encounters (approximately 100x the volume of a large IDN) and combines in-house replication of CMS methodologies (Star Ratings, VBP, HRRP, MSPB, HAC, BPCI, CMS TEAM) with an automated simulation engine that runs millions of scenarios to identify optimal improvement pathways. The platform achieved 99% predictive accuracy on 2024 CMS Star Ratings across 2,707 hospitals and ships event-level predictions for HAIs, PSIs, readmissions, mortality, HCAHPS, CMS TEAM, and bundled episodes. Product surface spans the core QSR platform plus add-ons including Dexur Pro (premium benchmarking for hospitals, home health, nursing homes, hospices, physicians, and life sciences), Dexur Predictions and Simulations, Real World Evidence risk factor analysis, incident management (patient safety, employee, infrastructure), and a Denials, Utilization and Revenue Cycle module covering denial prevention, utilization review, medical necessity, and appeals automation. The company also publishes the "Dexur Quality Education" newsletter, hosts weekly webinars, and supports peer-reviewed research collaborations including with Harvard Medical School (Brigham & Women's Hospital).

The business model is a sales-led enterprise SaaS model priced at $30,000 per hospital per year for the core quality module, bundled with advisory services and supplemented by Dexur Pro subscriptions and add-on modules. Go-to-market combines direct enterprise field sales (with Parkview Health as a documented flagship), association-led distribution through partnerships such as the Indiana Hospital Association, and a self-serve PLG layer via free hospital search and CMS Star Rating guidance on Dexur.com. Dexur claims more than 150 healthcare organization customers and serves multiple segments including independent and rural hospitals, hospital systems and IDNs, home health agencies, nursing homes, hospices, physicians, life sciences organizations, and state/regional hospital associations. The firm operates primarily in the United States (North America), is privately held with no disclosed funding rounds and no parent or institutional investor identified in the source materials, and reports 11-50 employees, consistent with a founder-controlled, organically funded mid-stage private company.

Name

Dexur

Legal name

Dexur Enterprises Private Limited

Website

https://dexur.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Dexur is a healthcare analytics SaaS company providing a unified quality, safety, risk, and incident management platform for hospitals and health systems, built on Medicare claims data with proprietary CMS algorithm replication to predict and improve CMS program outcomes.

Ownership category

akta.pro rank

Product category

Healthcare Quality Analytics Software

NAICS

Custom Computer Programming Services (541511), Accounting, Tax Preparation, Bookkeeping, and Payroll Services (54121)

SIC

Services-Prepackaged Software (7372), Finance Services (6199)

akta.pro primary industry

DEX Aggregators & Smart Order Routing (FSAPADAC)

Keywords

• Healthcare quality analytics
• Hospital quality software
• Predictive healthcare analytics
• CMS Star Ratings
• Denials management software

Headquarters

HQ city

Cheyenne

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. SaaS Platform Subscription (Per Hospital): Dexur operates on a subscription SaaS model priced at $30,000 per hospital per year, offering a unified quality, safety, risk, and incident management platform. The pricing is modular and scalable across hospitals, systems, and provider groups. The company also offers a free trial of monthly CMS Star Rating guidance snapshots.
2. Professional Advisory Services: Dexur provides advisory services alongside its technology platform, as evidenced by partnerships where Dexur provides advisory services (e.g., Parkview Health partnership). Advisory services appear to be bundled or sold alongside the SaaS platform.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

Dexur provides a unified Quality, Safety, Risk and Incident SaaS platform for hospitals and health systems, built on CMS-approved Medicare claims data with event-level predictive analytics, CMS algorithm replication (Star Ratings, VBP, HRRP, MSPB), automated simulation engines, and a separate Denials, Utilization and Revenue Cycle module. It sells per-hospital annual subscriptions plus advisory services, and offers Dexur Pro for premium research and benchmarking data.

Product overview

Dexur is a unified Quality, Safety, Risk & Incident Software platform for healthcare organizations. The core platform integrates Medicare claims data with predictive analytics to help hospitals predict and improve outcomes across CMS programs including Star Ratings, VBP, HRRP, and MSPB. Key modules include: the Dexur Quality, Safety, and Risk Platform (core unified platform); Dexur Predictions (predictive analytics forecasting CMS metrics 1-3 years ahead); Dexur Simulations (AI-driven scenario modeling for quality improvement); Dexur Measures & Data (centralized scorecards and analytics hub); Dexur RWE Risk Factors (Real World Evidence-based risk identification); Dexur Best Practices Research (evidence-based quality improvement blueprints); Denials, Utilization and Revenue Cycle Module (denial prevention and appeals automation); Dexur Quality Education (webinars and whitepapers); and Dexur Pro (premium research and benchmarking subscription). The platform is priced at $30k per hospital per year for the core quality module.

Differentiator

Problem solved

Functional benefit

Products and services

• Dexur Quality, Safety, and Risk Platform A unified, real-time SaaS platform delivering event-level predictive insights across quality, safety, and economic outcomes for CMS programs (Star Ratings, VBP, HRRP, MSPB, HAC, HCAHPS, Leapfrog, CMS TEAM). Includes predictions, simulations, measures and data scorecards, RWE risk factor analysis, and incident management. Targeted at hospitals and health systems, priced at $30,000 per hospital per year.
• Dexur Denials, Utilization and Revenue Cycle Module A platform connecting denial issue management, medical necessity/utilization review, denial prevention, and appeals automation to convert fragmented denial activity into measurable recovery and cash impact. Targeted at hospitals and health systems seeking revenue cycle improvement.
• Dexur Pro A premium subscription offering hospital-specific quality outcomes research, DRG-level analytics, surgeon-specific quality outcomes, market share analysis, and benchmarking capabilities for hospitals, home health agencies, nursing homes, hospices, and physicians.
• Dexur Quality Education Educational resource program offering webinars, white papers, posters, and articles focused on quality, safety, and risk topics for healthcare professionals, including a weekly newsletter for CEOs, CMOs, CNOs, CQOs, Quality, Safety, Compliance, Analytics and Performance teams.

Quantifiable outcome

• 99% predictive accuracy for 2024 CMS Star Ratings across 2,707 hospitals (27 incorrectly forecasted)
• +3 more outcomes

Named customers3 records

Segments7 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature7 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Indiana Hospital Association (IHA)coreStrategic or Co-development PartnerDexur and IHA entered a partnership to provide Indiana hospitals with free sample CMS program reports including Star Rating predictions, Readmission & Mortality forecasts for FY 2025 & 2026, and VBP/MSPB prediction reports. Dexur leverages IHA's platform to connect with hospitals across Indiana, providing predictions 12-36 months in advance based on Dexur's statistical algorithms and Medicare claims data.
• Parkview HealthcoreStrategic or Co-development PartnerParkview Health, a leading Indiana-based health system, partnered with Dexur to elevate its quality and value outcomes programs using Dexur's healthcare data, applications, and advisory services. Parkview utilizes Dexur's advisory services along with its data and technology platform for CMS VBP monitoring, HCAHPS improvement, HRRP readmission reduction, and MSPB optimization.
• Harvard Medical School / Brigham & Women's Hospital ResearcherscoreStrategic or Co-development PartnerDexur collaborates with researchers from Harvard Medical School (Brigham & Women's Hospital) to publish Real-World Evidence (RWE) based research papers in peer-reviewed publications. Research areas include opioid use impact on healthcare systems and patient outcomes. Dexur provides its large anonymized claims database and research support. Research has been published in journals including the American Journal of Medical Quality and Pain Practice (WILEY).
• Orthopedic Network NewsminorGTM or Marketing PartnerDexur provides critical volume and quality outcomes data to Orthopedic Network News, a leading orthopedic research publication read by orthopedic surgeons and hospitals. Data has been used to publish statistics on quality outcomes, care setting shifts (inpatient to outpatient), and emerging trends. The editor describes Dexur as a valued resource for national, hospital, and surgeon-specific healthcare data since 2018.
• American Society of Regional Anesthesia and Pain Medicine (ASRA)minorOthersASRA is one of the largest subspecialty medical societies in anesthesiology with 4,000+ members in 60 countries and 6 continents. Dexur's collaboration with Harvard Medical School researchers won the 'Resident/Fellow Best of Meeting Abstracts and Research Travel Award' at ASRA's 16th Annual Pain Medicine meeting in November 2017.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Vizient: Large healthcare performance improvement company offering benchmarking, analytics, and advisory to hospitals and IDNs. Comparable to Dexur on quality and safety benchmarking but operates at significantly greater scale with broader service portfolio.
• Premier Inc. Large healthcare improvement company offering quality benchmarking, supply chain, and performance analytics to hospitals. Overlaps with Dexur on hospital quality benchmarking and CMS program performance management, but operates as a much broader GPO and performance services business.

Direct peers

• Arcadia: Healthcare data analytics platform focused on value-based care, population health, and quality measure reporting for health systems. Directly competes with Dexur in hospital quality analytics, with comparable SaaS delivery and CMS-measure focus.
• Health Catalyst: Healthcare data and analytics platform serving hospitals and health systems with quality, cost, and outcomes analytics. Directly comparable to Dexur's Quality/Safety/Risk SaaS offering but at a substantially larger scale with broader enterprise footprint.
• Q-Centrix: Clinical data abstraction and quality reporting company serving hospitals with chart abstraction and CMS measure submission. Overlaps with Dexur on quality measure reporting and outcomes analytics, though Q-Centrix leans more toward outsourced clinical data services.
• Medisolv: Specialty vendor providing hospital quality measure reporting, eCQM submission, and CMS program analytics. Closely comparable to Dexur's measure reporting and quality program modules, often used as a reference point by small-to-mid hospital quality teams.

Emerging players

• Innovaccer: Healthcare data activation platform providing analytics, quality measure reporting, and population health tools. Comparable to Dexur on hospital and IDN quality analytics, though Innovaccer extends more deeply into payer-provider integrated workflows.
• Stratasan: Healthcare market intelligence and strategic analytics platform for hospitals and health systems. Comparable to Dexur Pro on market share, referral, and quality benchmarking, but focused more on strategic planning than CMS program compliance.
• Phrase Health: Healthcare quality improvement analytics platform focused on operationalizing clinical quality measures from EHR data. Comparable niche focus to Dexur on quality measure analytics but emerging-stage with smaller footprint.

Others

• LeanTaaS: Healthcare AI platform for hospital capacity, OR, and infusion scheduling. Adjacent to Dexur in hospital AI/data analytics with overlapping health-system buyer personas, but focused on operational capacity rather than quality/safety outcomes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/dexurhealth

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dexur